Chidozie Ugwumba is currently the Managing Partner at SymBiosis Capital Management and serves as a Board Member or Observer at various biotechnology companies such as Biosplice Therapeutics, Carisma Therapeutics, Micronoma, Clene Nanomedicine, PlateletBio, MaaT Pharma, and Enterome. With a background in business administration and political science from Cornell Johnson Graduate School of Management, Amherst College, and Phillips Academy, Chidozie has also held positions at WIT, LLC and Partners Group in the past.
Sign up to view 3 direct reports
Get started